- 4°28′02″E / 52.1655°N 4.4673°E / 52.1655; 4.4673
Janssen Vaccines,
formerly Crucell, is a
biotechnology company specializing in
vaccines and biopharmaceutical...
-
Cilag AG
Janssen Biotech (formerly Centocor)
Janssen Vaccines (formerly
Crucell)
Tibotec The
roots of what
would become Janssen Pharmaceuticals date back...
- GAVI-supported
countries to
introduce the five-in-one vaccine. In May 2010,
Crucell N.V.
announced a US$110
million award from
UNICEF to
supply its pentavalent...
-
prevention of typhoid: the live, oral Ty21a
vaccine (sold as
Vivotif by
Crucell Switzerland AG) and the
injectable typhoid polysaccharide vaccine (sold...
-
improve health for
expectant mothers and
their children. In May 2010,
Crucell N.V.
announced an
additional US$110
million award from
UNICEF to supply...
-
research spin-offs.
Prominent examples of
university spin-offs are Genentech,
Crucell,
Lycos and
Plastic Logic. In most countries,
universities can
claim the...
-
Solutions and the
Human Performance Institute. In
October 2010, J&J
acquired Crucell for $2.4 billion. The
subsidiary operates as the
centre for vaccines, within...
-
founded in 2012 by
Ronald Brus,
former CEO of the
biotechnology company Crucell. In the
beginning of its existence,
myTomorrows has been characterized...
-
continued through 2002.: 221 The
United States and the
Dutch company Crucell collaborated to
begin development on an
ebola vaccine in response.: 222 ...
- of
antigen adsorbed on
aluminium hydroxide (0.3 mg Al). Epaxal: made by
Crucell. Also sold
under the
brand names HAVpur and VIROHEP-A. This
vaccine consists...
